XML 32 R22.htm IDEA: XBRL DOCUMENT v3.26.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]
Three months ended March 31, 2026U.S. OperationsSwiss OperationsWestern European OperationsChinese OperationsOther OperationsTotal
Product Revenue$239,958 $38,375 $139,730 $140,053 $126,138 $684,254 
Service Revenue:
Point in time
80,198 8,952 48,068 8,613 37,001 182,832 
Over time
28,391 3,432 27,585 4,857 15,776 80,041 
Total$348,547 $50,759 $215,383 $153,523 $178,915 $947,127 
Three months ended March 31, 2025U.S. OperationsSwiss OperationsWestern European OperationsChinese OperationsOther OperationsTotal
Product Revenue$247,067 $36,298 $124,850 $128,197 $113,538 $649,950 
Service Revenue:
Point in time
73,330 8,248 42,476 8,822 29,915 162,791 
Over time
25,361 2,756 23,043 4,149 15,694 71,003 
Total$345,758 $47,302 $190,369 $141,168 $159,147 $883,744 
A breakdown of net sales to external customers by geographic customer destination for the three months ended March 31 follows:
20262025
Americas$389,339 $377,916 
Europe278,686 247,975 
Asia / Rest of World279,102 257,853 
Total$947,127 $883,744 
The Company's global revenue mix by product category is laboratory (55% of sales), industrial (40% of sales) and retail (5% of sales). The Company's product revenue by reportable segment is proportionately similar to the Company's global revenue mix except the Company's Swiss Operations is largely comprised of laboratory products, while the Company's Chinese Operations has a slightly higher percentage of industrial products. A breakdown of the Company’s sales by product category for the three months ended March 31 follows:
20262025
Laboratory$524,581 $500,224 
Industrial374,640 341,200 
Retail47,906 42,320 
Total$947,127 $883,744